Experts guarded as breast cancer test gets go-ahead
This article was originally published in Clinica
Executive Summary
Oncor's genetic test for predicting whether breast cancer will recur has been approved in the US. But the test should not be used alone when deciding whether to go ahead with post-surgical treatment, recommend experts.